Table 3.
Adverse events observed in the study
| Glucantime (N = 80) | NOP (N = 76) | P | |||||
|---|---|---|---|---|---|---|---|
| n | % | Days* | n | % | Days | ||
| Fever | 25 | 31.6 | 5.6 ± 3.3 | 10 | 13.7 | 3.5 ± 5.1 | 0.009 |
| Myalgia | 49 | 62.1 | 7.3 ± 4.2 | 16 | 21.9 | 7.6 ± 4.2 | 0.001 |
| Arthralgia | 41 | 51.9 | 7.3 ± 4.9 | 5 | 6.8 | 8.8 ± 5.5 | 0.001 |
| Headache | 42 | 53.2 | 6.5 ± 4.4 | 24 | 32.8 | 5.1 ± 3.9 | 0.01 |
| Vomiting | 5 | 6.3 | 1.7 ± 0.9 | 3 | 4.1 | 1.3 ± 0 0.6 | 0.54 |
| Nausea | 28 | 35.4 | 5.3 ± 4.4 | 10 | 13.7 | 4 ± 3.4 | 0.002 |
| Hyporexia | 25 | 31.6 | 5.9 ± 4.4 | 3 | 4.2 | 9.6 ± 7.2 | 0.001 |
| Local Rash | 8 | 10.1 | 6.4 ± 5.7 | 21 | 28.8 | 8.4 ± 6.1 | 0.003 |
| Local Pain | 4 | 5.1 | 7.5 ± 8.1 | 11 | 15.1 | 10.4 ± 7.5 | 0.03 |
*
Data shown as mean ± SD values.